Article Versions Notes

Tournier B, Aucagne R, Truntzer C, Fournier C, Ghiringhelli F, Chapusot C, Martin L, Bouvier AM, Manfredi S, Jooste V, et al. Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. Cancers. 2023; 15(1):158. https://doi.org/10.3390/cancers15010158

Tournier, Benjamin, Romain Aucagne, Caroline Truntzer, Cyril Fournier, François Ghiringhelli, Caroline Chapusot, Laurent Martin, Anne Marie Bouvier, Sylvain Manfredi, Valérie Jooste, and et al. 2023. "Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer" Cancers 15, no. 1: 158. https://doi.org/10.3390/cancers15010158

Tournier, B., Aucagne, R., Truntzer, C., Fournier, C., Ghiringhelli, F., Chapusot, C., Martin, L., Bouvier, A. M., Manfredi, S., Jooste, V., Callanan, M. B., & Lepage, C. (2023). Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer. Cancers, 15(1), 158. https://doi.org/10.3390/cancers15010158